Finally… A Fast & Effective In Practice or At-Home Treatment For Dry Eye Disease

Feb 7

NuLids improves results between doctor visits between office visits

– Dry eye patients report being far more comfortable

NuLids works

– NuLids’ oscillating Soft Tip design works by gently stimulating and rejuvenating the patient’s Meibomian Glands

– Study participants reported a 51% improvement in their OSDI scores citing a substantial reduction in both the severity and frequency of their dry eye symptoms after using the NuLids System for 30 days (1)

– NuLids has been shown to remove scurf, improve Meibomian Gland effectiveness, and increase Meibomian

output by 2x

– Studies demonstrated a 65% improvement in tear film breakup time [TBUT] and an 81% increase in Meibomian Gland Yielding Liquid Secretions in less than 30 days (1)

NuLids is safe

– NuLids offers a natural, more effective alternative in the treatment of dry eye disease

– NuLids did not damage corneal tissue when accidental contact was made (1’2)

– Self-regulating design halts movement of the NuLids Soft Tip if too much pressure is applied to the eye lid

NuLids is comfortable and easy to use

– 89% of patients surveyed said that they had NO discomfort when using the NuLids product (2)

– All patients surveyed said that the NuLids oscillating Soft Tip was more convenient than manual treatments

– 82% of patients found the NuLids device easier and more comfortable to use than manual lid scrubs

NuLids is quick

– With daily use, patients report a noticeable improvement in both the signs and symptoms of dry eye in as little as 8 days (3)

– Treatment takes just 1 minute per day

NuLids is cost effective and affordable

– NuLids can save the patient money

– NuLids patients report a significant reduction and/or elimination in their use of manual lid scrubs, articial tears, gels, ointments, warming masks and anti-inflammatory medications

(1) Olkowski, J Use of a personal at-home mechanical eyelid cleaning device for the treatment of dry eye disease, blepharitis and meibomian gland disease. ASCRS ASOA Abstract, Los Angeles, CA, 2016

(2) Data on file, NuSight Medical

(3) NuLids Patient comments available upon request